Vimarsana
Biggest News Aggregation in the World

Qnostics Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Qnostics Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Qnostics Ltd Today - Breaking & Trending Today

Global Molecular Quality Controls Market Report 2023: Sector to Reach $313.7 Million by 2030 at a 6.4% CAGR - Vimarsana News

Global Molecular Quality Controls Market Report 2023: Sector to Reach $313.7 Million by 2030 at a 6.4% CAGR

/PRNewswire/ -- The "Global Molecular Quality Controls Market Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. The total size of...

In Vitro Diagnostics (IVD) Quality Controls Global Market Report 2022: Growing Demand for Third-Party Controls Fueling Expansion - Vimarsana News

In Vitro Diagnostics (IVD) Quality Controls Global Market Report 2022: Growing Demand for Third-Party Controls Fueling Expansion

/PRNewswire/ -- The 'In Vitro Diagnostics (IVD) Quality Controls: Global Market' report has been added to ResearchAndMarkets.com's offering. Report Scope The...

Government 'fast and loose' over Covid contracts - Vimarsana News

Government 'fast and loose' over Covid contracts

An investigation points to failures in record-keeping but finds no evidence of improper awards.

Source: bbc.com
Government did not adequately record decisions on Covid contracts – watchdog - Vimarsana News

Government did not adequately record decisions on Covid contracts – watchdog

The National Audit Office said it has seen no evidence that Randox contracts were awarded ‘improperly’, but certain documentation was lacking.

COVID-19 procurement: Government did not properly document decisions around awarding contracts, says audit - Vimarsana News

COVID-19 procurement: Government did not properly document decisions around awarding contracts, says audit

The government has been accused of playing fast and loose with public money after an audit found it did not properly document key decisions made around procuring COVID-19 tests.